The best way to fight cancer is to detect and start treatment early. Dr Atangwho shares signs to watch out for prostate ...
Drs. Pallabi Mustafi and Ruben Raychaudhuri at Fred Hutch Cancer Center recently received Young Investigator Awards from the ...
A recent post hoc analysis assesses whether PSA changes can predict survival outcomes in patients with metastatic or very high risk nonmetastatic prostate cancer.
A Mansfield man's routine health screenings eventually uncovered cancer, but advanced robotic technology at Mount Carmel St.
Wayne Swan at his Brisbane home. This is not simply a policy initiative. For me, it is deeply personal. I have ...
Abeona Therapeutics (NASDAQ:ABEO) reported early commercial momentum for ZEVASKYN in the first quarter of 2026, with ...
NVision raises $38 million led by health diagnostics giant Abbott to scale up its groundbreaking cancer imaging system. Next ...
Ashwagandha is an adaptogenic botanical traditionally used in men's wellness formulations for stress reduction and hormonal ...
Legit.ng on MSN
"Life after scare": Nigerian celebrities who survived similar disease that killed Alex Ekubo
The reported death of Alex Ekubo from liver cancer sparks crucial discussions on cancer survival among Nigerian celebrities, ...
Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...
Medical Device Network on MSN
Rivermark pockets $20M in Series D for late-stage prostate device trial
The raise will support Rivermark’s pivotal trial, while allowing the medtech company to ready its FloStent system for ...
Three patients treated with ZEVASKYN- in Q1 2026 - - QTC network expands to six sites, with two new additions on the East Coast - - In-licensed radically novel engineered T-cell technology with game ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results